PlainRecalls
FDA Devices Moderate Class II Ongoing

Brivo MR355, NMRI system

Reported: March 5, 2025 Initiated: January 31, 2025 #Z-1240-2025

Product Description

Brivo MR355, NMRI system

Reason for Recall

For certain MR systems, a scan can be resumed following a Power Monitor trip when the "6-minute average SAR" is above the limit indicated on the "SAR Display". The user interface may incorrectly enable a scan to proceed earlier than intended. If resumed by the operator, such a scan can result in potential excessive tissue heating, especially if the patient is in contact with a conductive material or has an implant.

Details

Units Affected
22
Distribution
Domestic US distribution nationwide. International distribution worldwide.
Location
Beijing, N/A

Frequently Asked Questions

What product was recalled?
Brivo MR355, NMRI system. Recalled by GE Healthcare (China) Co., Ltd.. Units affected: 22.
Why was this product recalled?
For certain MR systems, a scan can be resumed following a Power Monitor trip when the "6-minute average SAR" is above the limit indicated on the "SAR Display". The user interface may incorrectly enable a scan to proceed earlier than intended. If resumed by the operator, such a scan can result in potential excessive tissue heating, especially if the patient is in contact with a conductive material or has an implant.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 5, 2025. Severity: Moderate. Recall number: Z-1240-2025.